A new therapeutic domain is hybrid peptides. Such engineered molecules combine portions from various protein sources, allowing the creation of distinct pharmacological functions. This approach presents a significant https://chimerapeptides254863.blog-avenue.com/61976631/chimera-peptides-a-novel-therapeutic-frontier